Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
The optimum use of intravenous immunoglobulin for prophylaxis of opportunistic infection in HIV-infected adultsM G Kiehl, C MüllerCritical Reviews in Oncology/Hematology|April 20, 2001
New therapeutic modalities in the treatment of graft-versus-host diseaseN Basara, M G Kiehl, A A FauserIntensive Care Medicine|May 1, 1997
Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shockM G Kiehl, H Ostermann, J Meyer, et al.Chest|November 21, 1997
Inflammatory mediators in BAL fluid as markers of evolving pneumonia in leukocytopenic patientsM G Kiehl, H Ostermann, M Thomas, et al.Transplantation|October 31, 2001
Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: report of an initial experienceB Grothaus-Pinke, S Günzelmann, A A Fauser, et al.Bone Marrow Transplantation|August 10, 2000
A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center studyA A Fauser, N Basara, I W Blau, et al.International Journal of Molecular Medicine|July 14, 1999
Tyrosine phosphorylation in peripheral T cells of kidney transplant recipients: analyses of baseline levels and response to T cell receptor stimulationC Müller, M Bonmann, S Heidenreich, et al.International Journal of Molecular Medicine|December 29, 1998
Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibitionC Müller, M G Kiehl, J van de Loo, et al.Bone Marrow Transplantation|August 10, 2000
New strategies in the treatment of graft-versus-host diseaseN Basara, I W Blau, W Willenbacher, et al.Pageof 3